Home › Funds › EQUITY INVESTMENT CORP › GSK

EQUITY INVESTMENT CORP position in GSK

GSK PLC · Health Care

EQUITY INVESTMENT CORP reported holding 3,560,824 shares of GSK (GSK PLC) in its Q3 2026 13F filing — a position valued at US$171.5M, representing 3.23% of its reported portfolio and ranking #4 among its reported holdings. EQUITY INVESTMENT CORP has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)3.56M sh
Reported value held$171.52M
Portfolio Weight3.23%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EQUITY INVESTMENT CORP's GSK position evolved

EQUITY INVESTMENT CORP first disclosed a stake in GSK in Q3 2023 at 3,277,362 shares (US$118.8M). The position peaked in Q4 2025 at 4,110,579 shares, worth US$201.6M. Across 13 filings, EQUITY INVESTMENT CORP increased the stake 8 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 3,560,824 shares valued at US$171.5M — an increase of 291,059 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.28M $118.80M New
Q4 2023 3.24M $120.20M Reduce
Q1 2024 3.40M $145.70M Add
Q2 2024 3.43M $132.18M Add
Q3 2024 3.50M $142.93M Add
Q4 2024 3.96M $134.01M Add
Q1 2025 4.17M $161.71M Add
Q2 2025 4.19M $161.00M Hold
Q3 2025 4.27M $184.27M Add
Q4 2025 4.11M $201.58M Reduce
Q1 2026 3.22M $177.77M Reduce
Q2 2026 3.27M $171.40M Add
Q3 2026 3.56M $171.52M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GSK and 13F data

GSK (GSK PLC) is a Health Care company. 19 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.21B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GSK

All GSK fund holders →

FAQ

How long has EQUITY INVESTMENT CORP held GSK?

EQUITY INVESTMENT CORP has disclosed GSK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EQUITY INVESTMENT CORP's current position in GSK?

As of Q3 2026, EQUITY INVESTMENT CORP holds 3.56M shares of GSK (GSK PLC), valued at $171.52M, representing 3.23% of its reported portfolio and ranking #4.

Has EQUITY INVESTMENT CORP been buying or selling GSK?

In the latest 13F filing (Q3 2026), EQUITY INVESTMENT CORP increased its position in GSK. The position peaked in Q4 2025 at 4.11M shares.

Which other funds hold GSK?

Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.